Childhood Vaccine Development: An Overview

Pediatric Research

Volumn 55, Issue 2, 2004, Pages 347-356

  Baker, Jeffrey P ^a   Katz, Samuel L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; VACCINE;

BACTERIUM CULTURE; CHILDHOOD DISEASE; IMMUNIZATION; MEASLES VACCINATION; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS CULTURE;

BACTERIAL VACCINES; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; VACCINATION; VIRAL VACCINES;

EID: 1642474311     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000106317.36875.6A     Document Type: Review

References (62)

1. Radetsky M 1999 Smallpox: a history of its rise and fall. Pediatr Infect Dis 18:85-93
2. Geison GL 1995 The Private Science of Louis Pasteur. Princeton University Press. Princeton, NJ, pp 177-258
3. Hansen B 1998 America's first medical breakthrough: how popular excitement about a French rabies cure in 1885 raised new expectations for medical progress. Am Hist Rev 103:373-418
4. Foster WD 1970 A History of Medical Bacteriology and Immunology. William Heinemann Medical Books, London, UK, pp 127-164
5. Smith KC, Starke JR 1999 Bacille Calmette-Guérin. In: Plotkin SA, Orenstein W (eds) Vaccines, 3rd Ed. WB Saunders, Philadelphia, pp 111-139
6. Smith FB 1988 The Retreat of Tuberculosis, 1850-1950. Croom Helm, London, UK, pp 194-203
7. Feldberg GD 1995 Disease and Class: Tuberculosis and the Shaping of Modern North American Society. Rutgers University Press, New Brunswick, NJ, pp 1-214
8. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F 1994 Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698-702
9. Metaxas Quiroga VA 1990 Diphtheria and medical therapy in late 19th century New York City. NY State J Med 90:256-262
10. Parish HJ 1965 A History of Immunization. E.& S. Livingstone, Edinburgh, pp 141-154
11. Park WH 1923 The control of diphtheria. Am J Public Health 13:23-32
12. Hammonds EM 1999 Childhood's Deadly Scourge: The Campaign to Control Diphtheria in New York City, 1880-1930. Johns Hopkins University Press, Baltimore, pp 1-299
13. Lévy FM 1975 The fiftieth anniversary of diphtheria and tetanus immunization. Prev Med 4:226-237
14. Elderling G 1971 Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: historical notes on pertussis immunization. Health Lab Sci 8:200-205
15. Medical Research Council 1959 Vaccination against whooping-cough: the final report to the whooping cough committee of the Medical Research Council. BMJ 1:994-1000
16. Kilbourne ED 1996 A race with evolution - a history of influenza vaccines. In: Plotkin SA, Fantini B (eds) Vaccines, Vaccination, Vaccinology: Jenner, Pasteur and Their Successors. Elsevier, Amsterdam, pp 183-188
17. Enders JF, Weller TH, Robbins FC 1949 Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109:85-87
18. Smith JS 1990 Patenting the Sun: Polio and the Salk Vaccine. William Morrow and Co, New York, pp 1-378
19. Berk LB 1989 Polio vaccine trials of 1935. Trans Stud Coll Physicians Phila 11:321-337
20. Bendiner E 1983 Salk: adulation, animosity, and achievement. Hosp Pract 18:194-218
21. Lambert SM, Markel H 2000 Making History: Thomas Francis, Jr MD, and the 1954 Salk Poliomyelitis Vaccine Field Trial. Arch Pediatr Adolesc Med 154:512-517
22. Benison S 1982 International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine, and the Soviets. Bull Hist Med 56:460-483
23. Nathanson N, Langmuir AD 1963 The Cutter incident-poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. Am J Hyg 78:16-81
24. Immunization Safety Review Committee, Institute of Medicine 2002 Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer. National Academies Press, Washington, DC, pp 1-72
25. Robbins FC 1999 The history of polio vaccine development. In: Plotkin SA, Orenstein W (eds) Vaccines, 3rd Ed. WB Saunders, Philadelphia, pp 13-27
26. Enders JF, Katz SL, Milovanovic MB, Holloway A 1960 Studies on an attenuated measles virus vaccine. I. Development and preparation of the vaccine. N Engl J Med 263:153-159
27. Katz SL 1996 The history of measles vaccine and attempts to control measles. In: Koprowski H, Oldstone MBA (eds) Microbe Hunters-Then and Now. Medi-Ed Press. Bloomington, IL, pp 69-76
28. Fulginiti VA, Eller JJ, Downie AW, Kempe CH 1967 Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:1075-1080
29. Vivier PM 1996 National Policies for Childhood Immunization in the United States: An Historical Perspective. Dissertation, Johns Hopkins University, UMI Dissertation Services, Ann Arbor, MI, pp 77-78
30. Plotkin SA 1999 Rubella vaccine. In: Plotkin SA, Orenstein W (eds) Vaccines, 3rd Ed. WB Saunders, Philadelphia, pp 409-440
31. Galambos L, Sewell JE 1995 Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895-1995. Cambridge University Press, Cambridge, UK, pp 1-255
32. Owens CS, Espino RT 1989 Rubella in Panama: still a problem. Pediatr Infect Dis 8:110-115
33. Plotkin SA 1996 History of rubella vaccines and the recent history of cell culture. In: Plotkin SA, Fantini B (eds) Vaccines, Vaccination, Vaccinology: Jenner, Pasteur and Their Successors. Elsevier. Amsterdam, pp 271-282
34. Buynak EB, Hilleman MR 1966 Live attenuated mumps virus vaccine: I. Vaccine development. Proc Soc Exp Biol Med 123:768-775
35. National Vaccine Advisory Committee 1991 The measles epidemic: the problems, barriers, and recommendations. JAMA 266:1547-1552
36. Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, Bellini WJ 2002 Molecular epidemiology of measles viruses in the United States: 1997-2001. Emerg Infect Dis 8:902-908
37. Silverstein AM 1981 Pure Politics and Impure Science: The Swine Flu Affair. Johns Hopkins University Press, Baltimore, pp 1-176
38. Kurland LT, Wiederholt WC, Kirkpatrick JW, Potter HG, Armstrong P 1985 Swine influenza vaccine and Guillain-Barré syndrome: epidemic or artifact? Arch Neurol 42:1089-1090
39. Kitch EW, Evans G, Gopin R 1999 U.S. law. In: Plotkin SA, Orenstein W (eds) Vaccines, 3rd Ed. WB Saunders, Philadelphia, pp 1165-1185
40. Hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, U.S. Senate, 97th Congress, 2nd session, July 22, 1982, pp 1-5
41. Hinman AR 1986 DTP vaccine litigation. Am J Dis Child 140:528-530
42. Smith MH 1988 National Childhood Vaccine Injury Compensation Act. Pediatrics 82:264-269
43. Institute of Medicine 1985 New Vaccine Development: Establishing Priorities. National Academy Press, Washington, DC, pp 1-458
44. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD 1982 Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347-350
45. Kumura M, Kuno-Sakai H 1991 Pertussis vaccines in Japan - a clue towards understanding of Japanese attitude to vaccines. J Trop Pediatr 37:45-47
46. Edwards KM, Decker MD 1996 Acellular pertussis vaccines for infants. N Engl J Med 334:391-392
47. Institute of Medicine 1991 Adverse Effects of Pertussis and Rubella Vaccines. National Academy Press, Washington, DC, pp 86-118
48. Gershon A, Steinberg S, Gelb L, NIAID Collaborative Varicella Vaccine Study Group 1984 Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252:355-362
49. Gershon A, LaRussa P, Steinberg S 1996 Live attenuated varicella vaccine. In: Koprowski H, Oldstone MBA (eds) Microbe Hunters-Then and Now. Medi-Ed Press, Bloomington, IL, pp 173-184
50. Smith DH, Peter G, Ingram DL, Harding AL, Anderson P 1973 Responses of children immunized with capsular polysaccharide Haemophilus influenzae type b. Pediatrics 52:637-644
51. Peter G 1998 Commentary. Pediatrics 102:252-253
52. Robbins JB, Schneerson R 1990 Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 161:821-832
53. [No authors listed] 2002 Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-United States, 1998-2000. MMWR Morb Mortal Wkly Rep 51:234-237
54. Austrian R 1999 A brief history of pneumococcal vaccines. Drugs Aging 15(suppl):S1-S9
55. Advisory Committee on Immunization Practices, Centers for Disease Control 2000 Preventing pneumococcal disease among infants. MMWR Morb Mortal Wkly Rep 49:1-38
56. Jordan W 2002 Jordan perspective: pneumococcal vaccine. In: National Institute of Allergy and Infectious Diseases, The Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002. Government Printing Office, Washington, DC, pp 207-208
57. Miller E, Salisbury D, Ramsay M 2002 Planning, registration, and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(suppl):S58-S67
58. Rennels MB 2000 The rotavirus vaccine story: a clinical investigator's view. Pediatrics 106:123-125
59. Mowery DC, Michell V 1995 Improving the reliability of the U.S. vaccine supply: an evaluation of alternatives. J Health Polit Policy Law 20:973-999
60. National Vaccine Advisory Committee 1997 U.S. vaccine research: a delicate fabric of public and private collaboration. Pediatrics 100:1015-1020
61. [No author listed] 1994 Bumps on the vaccine road. Science 265:1371-1379
62. Liu MA, Ulmer JB, O'Hagan D 2002 Vaccine technologies. In: National Institute of Allergy and Infectious Diseases, The Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002. Government Printing Office, Washington, DC, pp 39-43